Evidence map›Paper›PMID 34618283›Full record

Observational studyJournal of clinical psychology in medical settings2022

Affective Comorbidity Associated with Symptoms, Lung Function, and Differences Between Patients with COPD for Biomass and Tobacco Smoke Exposure.

Andrea Hernández-Pérez, Inés Vargas-Núñez, Bernardo Moreno-Jiménez, Rogelio Pérez-Padilla, Alejandra Ramírez-Venegas

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of clinical psychology in medical settings, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Andrea Hernández-PérezDepartment of Research in Tobacco and COPD, National Institute of Respiratory Diseases Ismael Cosío Villegas, Calzada de Tlalpan 4502, Col. Sección XVI, Alcaldía Tlalpan, C.P. 14080, Mexico City, Mexico. andrea.hernandez@iner.gob.mx.ORCID 0000-0001-8060-4661
Inés Vargas-NúñezFaculty of Higher Studies Zaragoza, National Autonomous University of México, Mexico City, Mexico.
Bernardo Moreno-JiménezDepartment of Research in Stress and Health, Autonomous University of Madrid, Madrid, Spain.
Rogelio Pérez-PadillaDepartment of Research in Tobacco and COPD, National Institute of Respiratory Diseases Ismael Cosío Villegas, Calzada de Tlalpan 4502, Col. Sección XVI, Alcaldía Tlalpan, C.P. 14080, Mexico City, Mexico.
Alejandra Ramírez-VenegasDepartment of Research in Tobacco and COPD, National Institute of Respiratory Diseases Ismael Cosío Villegas, Calzada de Tlalpan 4502, Col. Sección XVI, Alcaldía Tlalpan, C.P. 14080, Mexico City, Mexico.
Universidad Nacional Autónoma de México · MXEl Colegio de México · MXUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anxiety and depression are common entities in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). This study aimed to determine the prevalence of affective comorbidity (depression and anxiety) associated with lung function, functional capacity, dyspnea, and quality of life; as well as the differences between groups of patients diagnosed with COPD associated with biomass (COPD-BE) and patients with COPD secondary to tobacco (COPD-TS). Comparative cross-sectional observational study. Multiple hierarchical regression models, analysis of variance, and covariance were carried out. A total of 291 COPD patients were evaluated, symptoms of depression were found to be higher in patients with COPD-BE than in patients with COPD-TS (5.3 ± 4.2 versus 4.2 ± 4, 1, p = 0.016), as well as anxiety complications (4.1 ± 3.8 versus 3.8 ± 3.3, p = 0.095), although with anxiety it was not statistically significant, being adjusted for age and FEV1. Patients with COPD-BE had higher prevalence of depression, compared to COPD-TS (41.2% versus 27.7%, p = 0.028). In the multivariate regression models, the variables of dyspnea and quality of life were associated with depression and anxiety, explaining 25% and 24% of the variability, respectively. Depression is higher in COPD-BE patients compared to COPD-TE patients, it is necessary to consider affective comorbidity in routine evaluation and provide a comprehensive intervention to prevent the effects on other clinical conditions of the disease.

Indexed as

Pulmonary Disease, Chronic ObstructiveTobacco Smoke PollutionAnxietyBiomassComorbidityCross-Sectional StudiesDepressionDyspneaHumansLungQuality of LifeTobacco Smoke PollutionAnxietyChronic obstructive pulmonary diseaseComorbidityDepression

Identifiers

PMID34618283
OpenAlexW3201921362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.